Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Effect on Pancreatic Hormones and Size
NCT03520062Completed
- Start
- Aug 2017
- Primary completion
- Apr 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of liraglutide in obesity. Primary endpoint: Volumetric Changes of the Pancreas at 6 weeks. Started Aug 2017; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03520062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03520062.